Search Results - "Beer, T. M."

Refine Results
  1. 1

    Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study by Slovin, S.F., Higano, C.S., Hamid, O., Tejwani, S., Harzstark, A., Alumkal, J.J., Scher, H.I., Chin, K., Gagnier, P., McHenry, M.B., Beer, T.M.

    Published in Annals of oncology (01-07-2013)
    “…This phase I/II study in patients with metastatic castration-resistant prostate cancer (mCRPC) explored ipilimumab as monotherapy and in combination with…”
    Get full text
    Journal Article
  2. 2

    Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials by Saad, F, Ivanescu, C, Phung, D, Loriot, Y, Abhyankar, S, Beer, T M, Tombal, B, Holmstrom, S

    Published in Prostate cancer and prostatic diseases (01-03-2017)
    “…Background: We investigated the impact of skeletal-related events (SREs) on health-related quality of life (HRQoL) in patients with metastatic…”
    Get full text
    Journal Article
  3. 3

    Implementation of a Process Analytical Technology System in a Freeze-Drying Process Using Raman Spectroscopy for In-Line Process Monitoring by De Beer, T. R. M, Allesø, M, Goethals, F, Coppens, A, Vander Heyden, Y, Lopez De Diego, H, Rantanen, J, Verpoort, F, Vervaet, C, Remon, J. P, Baeyens, W. R. G

    Published in Analytical chemistry (Washington) (01-11-2007)
    “…The aim of the present study was to propose a strategy for the implementation of a Process Analytical Technology system in freeze-drying processes. Mannitol…”
    Get full text
    Journal Article
  4. 4

    Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer by Beer, T. M., Pierce, W. C., Lowe, B. A., Henner, W. D.

    Published in Annals of oncology (01-09-2001)
    “…Summary Background This study sought to define the activity and toxicity of weekly docetaxel in patients with androgen-independent prostate cancer and…”
    Get full text
    Journal Article
  5. 5

    Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium by Beer, T M, Smith, D C, Hussain, A, Alonso, M, Wang, J, Giurescu, M, Roth, K, Wang, Y

    Published in British journal of cancer (21-08-2012)
    “…Background: Preclinical studies in prostate cancer (PC) models demonstrated the anti-tumour activity of the first fully synthetic epothilone, sagopilone. This…”
    Get full text
    Journal Article
  6. 6

    Freeze-drying of live virus vaccines: A review by Hansen, L.J.J, Daoussi, R, Vervaet, C, Remon, J.-P, De Beer, T.R.M

    Published in Vaccine (13-10-2015)
    “…Abstract Freeze-drying is the preferred method for stabilizing live, attenuated virus vaccines. After decades of research on several aspects of the process…”
    Get full text
    Journal Article
  7. 7

    Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer by BEER, T. M, GARZOTTO, M, HENNER, W. D, EILERS, K. M, WERSINGER, E. M

    Published in British journal of cancer (18-10-2004)
    “…Recently, completed phase III studies demonstrated a survival benefit for a fixed number of cycles of docetaxel-containing chemotherapy treatment of…”
    Get full text
    Journal Article
  8. 8

    In-line and real-time process monitoring of a freeze drying process using Raman and NIR spectroscopy as complementary process analytical technology (PAT) tools by De Beer, T R M, Vercruysse, P, Burggraeve, A, Quinten, T, Ouyang, J, Zhang, X, Vervaet, C, Remon, J P, Baeyens, W R G

    Published in Journal of pharmaceutical sciences (01-09-2009)
    “…The aim of the present study was to examine the complementary properties of Raman and near infrared (NIR) spectroscopy as PAT tools for the fast, noninvasive,…”
    Get more information
    Journal Article
  9. 9

    Intermittent chemotherapy in metastatic androgen-independent prostate cancer by BEER, T. M, GARZOTTO, M, HENNER, W. D, EILERS, K. M, WERSINGER, E. M

    Published in British journal of cancer (15-09-2003)
    “…Intermittent use of chemotherapy for androgen-independent prostate cancer (AIPC) instead of treatment until disease progression may reduce toxicity. We…”
    Get full text
    Journal Article
  10. 10

    Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer by Armstrong, A.J., Lin, P., Higano, C.S., Sternberg, C.N., Sonpavde, G., Tombal, B., Templeton, A.J., Fizazi, K., Phung, D., Wong, E.K., Krivoshik, A., Beer, T.M.

    Published in Annals of oncology (01-11-2018)
    “…Prognostic models are needed that reflect contemporary practice for men with metastatic castration-resistant prostate cancer (mCRPC). We sought to identify…”
    Get full text
    Journal Article
  11. 11

    Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL by Graff, J.N., Baciarello, G., Armstrong, A.J., Higano, C.S., Iversen, P., Flaig, T.W., Forer, D., Parli, T., Phung, D., Tombal, B., Beer, T.M., Sternberg, C.N.

    Published in Annals of oncology (01-02-2016)
    “…Prostate cancer disproportionately affects older men. Because age affects treatment decisions, it is important to understand the efficacy and tolerability of…”
    Get full text
    Journal Article
  12. 12

    Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL by Bryce, A H, Alumkal, J J, Armstrong, A, Higano, C S, Iversen, P, Sternberg, C N, Rathkopf, D, Loriot, Y, de Bono, J, Tombal, B, Abhyankar, S, Lin, P, Krivoshik, A, Phung, D, Beer, T M

    Published in Prostate cancer and prostatic diseases (01-06-2017)
    “…Background: Advanced prostate cancer is a phenotypically diverse disease that evolves through multiple clinical courses. PSA level is the most widely used…”
    Get full text
    Journal Article
  13. 13

    Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer by Tiffany, N.M, Wersinger, E.M, Garzotto, M, Beer, T.M

    Published in Urology (Ridgewood, N.J.) (01-05-2004)
    “…To determine the safety and efficacy of zoledronic acid (Zometa) combined with imatinib mesylate (Gleevec) in patients with bone pain due to…”
    Get full text
    Journal Article
  14. 14

    Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process by De Beer, T.R.M., Bodson, C., Dejaegher, B., Walczak, B., Vercruysse, P., Burggraeve, A., Lemos, A., Delattre, L., Heyden, Y. Vander, Remon, J.P., Vervaet, C., Baeyens, W.R.G.

    “…The aim of this study is to propose a strategy to implement a PAT system in the blending step of pharmaceutical production processes. It was examined whether…”
    Get full text
    Journal Article
  15. 15

    Delayed therapy with curative intent in a contemporary prostate cancer watchful‐waiting cohort by El‐Geneidy, M., Garzotto, M., Panagiotou, I., Hsieh, Y.‐C., Mori, M., Peters, L., Klein, T., Beer, T.M.

    Published in BJU international (01-03-2004)
    “…OBJECTIVE To identify predictors of delayed therapy with curative intent, an increasingly common option in contemporary patients with prostate cancer who…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Influence of formulation and process parameters on the release characteristics of ethylcellulose sustained-release mini-matrices produced by hot-melt extrusion by Verhoeven, E., De Beer, T.R.M., Van den Mooter, G., Remon, J.P., Vervaet, C.

    “…Mini-matrices (multiple unit dosage form) with release-sustaining properties were developed by hot-melt extrusion (cylindrical die: 3 mm) using metoprolol…”
    Get full text
    Journal Article
  18. 18

    Perpetuating effects of androgen deficiency on insulin resistance by Cameron, J L, Jain, R, Rais, M, White, A E, Beer, T M, Kievit, P, Winters-Stone, K, Messaoudi, I, Varlamov, O

    Published in International Journal of Obesity (01-12-2016)
    “…Background/Objectives: Androgen deprivation therapy (ADT) is commonly used for treatment of prostate cancer but is associated with side effects, such as…”
    Get full text
    Journal Article
  19. 19

    Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers by De Beer, T.R.M., Wiggenhorn, M., Hawe, A., Kasper, J.C., Almeida, A., Quinten, T., Friess, W., Winter, G., Vervaet, C., Remon, J.P.

    Published in Talanta (Oxford) (15-02-2011)
    “…The aim of the present study was to examine the possibilities/advantages of using recently introduced in-line spectroscopic process analyzers (Raman, NIR and…”
    Get full text
    Journal Article
  20. 20

    Importance of Using Complementary Process Analyzers for the Process Monitoring, Analysis, and Understanding of Freeze Drying by De Beer, T. R. M, Wiggenhorn, M, Veillon, R, Debacq, C, Mayeresse, Y, Moreau, B, Burggraeve, A, Quinten, T, Friess, W, Winter, G, Vervaet, C, Remon, J. P, Baeyens, W. R. G

    Published in Analytical chemistry (Washington) (15-09-2009)
    “…The aim of the present paper is to demonstrate the importance of using complementary process analyzers (PAT tools) for the process monitoring, analysis, and…”
    Get full text
    Journal Article